Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taikang Tongji (Wuhan) Hospital is a large-scale, modern tertiary general hospital located in Wuhan, China, established by Taikang Insurance Group. The facility was developed through a strategic partnership with the prestigious Tongji Hospital of Huazhong University of Science and Technology. It gained significant prominence in early 2020 when it was rapidly completed and repurposed as a designated hospital to combat the COVID-19 pandemic. Currently, the hospital provides comprehensive medical services with a focus on oncology, geriatrics, and cardiovascular diseases, integrating clinical treatment with academic research and medical education. As a key component of Taikang's healthcare strategy, it aims to provide high-quality, patient-centered care supported by advanced medical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taikang Tongji Hospital.